News Home » Medical and Pharma » Drugmakers see a pricing blueprint in an $850,000 gene therapy

Around the World

Drugmakers see a pricing blueprint in an $850,000 gene therapy

James Bay 3 Jan 12
Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for getting paid for highly expensive – and effective – new medicines.